biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by unclepiemanon May 30, 2014 12:55pm

210 Views

Post# 22615310

RE:bbb

you have been saying the same thing over over a year now...
"once the market gets wind of what's going on here"

no one doubts the final result but the question everyone has had is When and Why hasnt the market got a wind of BTI in the last year and a half with such great achievements

sorry but going back to my comment last week, BTI is not big enough for major playes to care so until a time that we sign an actual deal... BTI will go unseen! fight me on this all you want, what we say here are simpy openions and comments and not going to impact anything else but egos

Bullboard Posts

The top 10 Canadian medical stocks